Trial intelligence / Profile preview

AMD3100 + G-CSF for Stem Cell Mobilization in Fanconi Anemia

NCT00479115Phase 2Completed

Sponsor
Cincinnati Children's Hospital Medical Center
Start
May 2007
Primary completion
Dec 2010
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of plerixafor in Fanconi anemia (FA), sponsored by Cincinnati Children's Hospital Medical Center. Started May 2007; status: completed.

02

Drugs

plerixafor
03

Conditions

Fanconi anemia (FA)

Beyond the preview

Go deeper on NCT00479115.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00479115.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call